Riboscience LLC

Pioneering RNA Therapeutics and Precision Medicine Innovation

Palo Alto, United States · Founded 2017

Employees
1–10
Founded
2017
Business Model
B2G
Last Round
GrantAug 2017
Rounds
2

About

Riboscience is a clinical-stage biotechnology company developing ribose-based small molecule drugs for oncology and virology using structure-guided design. Their lead candidate RBS2418, an oral ENPP1 inhibitor and cancer immunotherapy, has completed Phase 1a dose escalation and is advancing into Phase 2 clinical trials. The company leverages a proprietary nucleoside platform to discover first-in-class and best-in-class therapeutics.

Summary

Riboscience LLC is a Biotech company based in Palo Alto, United States, founded in 2017. Its most recent funding was a Grant round in Aug 2017.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundAug 2017

Sign up to see all 2 rounds

Grant through Seed — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Riboscience LLC on Indexed.vc
<a href="https://indexed.vc/companies/riboscience-llc"><img src="https://indexed.vc/api/badge/company/riboscience-llc" alt="Riboscience LLC on Indexed.vc" width="260" height="76" /></a>